Except for the study, the association between resistin levels and cancer risk was still significant (OR = 1.18, 95% CI = 1.09-1.28, I2 = 5.0%, P (for heterogeneity analysis) = 0.396) (Figure S2a). This evidence concerns the gene RETN and cancer.